Fierce Pharma

JANUARY 30, 2024

2seventy Bio has traveled a difficult path ever since it spun out from bluebird bio to work on cancer cell therapies. | 2seventy Bio has traveled a difficult path ever since it spun out from bluebird bio to work on cancer cell therapies. Now, the company is splitting in two once again, passing its R&D programs to Regeneron and going all-in on its Bristol Myers Squibb-partnered CAR-T Abecma.

275

275

Dominic Tyer

JANUARY 30, 2024

Successful customer engagement will require pharma companies to maintain a rigid focus throughout the journey

Pharma 130

Pharma Pharmaceutical Marketing 130

Fierce Pharma

JANUARY 30, 2024

A nasal gel version of the motion sickness drug scopolamine has failed to make the grade with the FDA. The U.S. | A nasal gel version of the motion sickness drug scopolamine has failed to make the grade with the FDA. The U.S. regulator has sent a complete response letter to Defender Pharmaceuticals, rejecting DPI-396 for the prevention of nausea and vomiting induced by motion.

FDA 253

FDA Pharma Pharmaceutical 253

MedCity News

JANUARY 30, 2024

Even just a year ago, we couldn’t fathom a cure for cancer. Now, we can. Artificial intelligence (AI) is rapidly transforming the healthcare industry, with its ability to process and analyze vast amounts of data. Cancer treatment is one area that could benefit significantly from AI, as it can aid in early detection, precise diagnosis, and personalized treatment plans.

Side effects 125

Side effects Ethics Medical Patients 125

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JANUARY 30, 2024

After 'bad launch' remark by CEO, Pfizer's RSV vaccine gains traction in Q4. How will it fare in latest round of GSK showdown?

300

300

pharmaphorum

JANUARY 30, 2024

From today, a new feature added to the NHS App used in the UK will allow millions of people to submit and view prescriptions, in a bid to save time for patients and doctors. The digital prescription function, which does away with the need for paper scrip, was put through its paces in a pilot trial last year involving a million users of the app, now being used by three-quarters of the UK population or around 33.5 million people.

Prescription 112

Prescription Doctors Patients 112

MedCity News

JANUARY 30, 2024

Chronic pain, an enduring concern for many older adults, is no longer confined to the traditional realm of pharmaceuticals. While traditional pain management methods like medication were once the go-to approach, alternative therapies are emerging as a viable and holistic approach to addressing this issue.

Management 111

Management Medical Pharmaceutical Education 111

pharmaphorum

JANUARY 30, 2024

Legislation filed in the US is seeking to block Chinese biotech companies from federal contracts on the grounds they are a national security concern

111

111

MedCity News

JANUARY 30, 2024

A preview of ViVE 2024 offers a sneak peek at the agenda and how the Payer and Provider Connect meeting platform initiatives have been revamped to maximize the quantity and quality of meeting for healthcare executives.

Healthcare 112

Healthcare Healthcare 112

European Pharmaceutical Review

JANUARY 30, 2024

The European Medicine Agency’s human medicines committee (CHMP) recommended marketing authorisations for the regulatory approval of three medicines at its January 2024 meeting last week. The CHMP recommended Exblifep (cefepime/enmetazobactam) as a treatment for complicated urinary tract infections, including pyelonephritis, hospital-acquired pneumonia, including ventilator associated pneumonia, and for treating bacteraemia caused by the aforementioned infections.

Medicine 98

Medicine Marketing Safety Pharmaceutical 98

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

JANUARY 30, 2024

As key opinion leaders (KOLs), nurses can provide insights on unmet clinical needs, identify gaps in treatment options, and contribute to the development of better and more patient-centric solutions. Here are three core reasons why pharmaceutical companies should tap the power of nurses.

Pharma 108

Pharma Pharmaceutical Patients Biopharma 108

European Pharmaceutical Review

JANUARY 30, 2024

Results from a Phase III, randomised, placebo-controlled clinical trial have for the first time in fifty years, demonstrated an overall survival benefit from an adjuvant therapy in kidney cancer. Pembrolizumab targets a “checkpoint” pathway that is key in enabling cancer cells to avoid being destroyed by the immune system. As a result, the immunotherapy drug supports the immune system’s T cells fight tumours, the researchers highlighted.

Patients 98

Patients Pharmaceutical 98

MedCity News

JANUARY 30, 2024

Regeneron Pharmaceuticals is paying $5 million up front for 2seventy bio’s cancer drug pipeline. 2seventy will now focus on a cell therapy commercialized with partner Bristol Myers Squibb while Regeneron adds assets for its newly formed cell therapy division.

Pharmaceutical 110

Pharmaceutical Biopharma Pharma 110

pharmaphorum

JANUARY 30, 2024

Elon Musk’s Neuralink company has said it has implanted its wireless brain implant device into a human being for the first time

114

114

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

JANUARY 30, 2024

Proven to offer cost-effective solutions, Real-Time Location Systems (RTLS) can ease operational burdens for efficiency and enhance the relationship between patients and caregivers, enabling a more human-focused experience for all.

Patients 101

Patients 101

Pharmaceutical Technology

JANUARY 30, 2024

The EMA has accepted GSK’s regulatory application seeking expansion of its RSVvaccine, Arexvy, to include adults aged 50 to 59 years.

105

105

MedCity News

JANUARY 30, 2024

Anne Osdoit, CEO of Moon Surgical, explains how the Maestro System may be expanding the surgical robotics pie by bringing the capability to newer markets and how surgical robotics do not have to break the bank.

Marketing 103

Marketing 103

Pharmaceutical Technology

JANUARY 30, 2024

Vertex is planning to submit a new drug application to the FDA following the announcement of its Phase III programme meeting its primary endpoint.

FDA 96

FDA 96

Advertisement

MedCity News

JANUARY 30, 2024

For the first episode of 2024, Senior Reporter Katie Adams discussed some executive hires, promotions and departures that recently took place in the healthcare world, as well as layoffs affecting the industry. We also hear from Kristin Myers, who recently became Northwell Health’s first chief digital officer.

Healthcare 100

Healthcare Healthcare 100

pharmaphorum

JANUARY 30, 2024

Vertex Pharma says its much-anticipated non-opioid painkiller, VX-548, clears two phase 3 trials en route to an FDA filing later this year

FDA 94

FDA Pharma 94

MedCity News

JANUARY 30, 2024

Blue Shield of California Promise Health Plan is working with the GED Testing Service to help members earn a General Educational Development (GED) diploma for no cost. Members can register online and gain access to GED study materials in both English and Spanish.

Education 96

Education 96

PharmaTimes

JANUARY 30, 2024

Type 2 diabetes is estimated to affect 462 million people worldwide

114

114

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

MedCity News

JANUARY 30, 2024

Valendo Health, the newest startup built at Redesign Health, launched on Tuesday. The startup partners with independent endocrinology practices and provides technology to help them thrive in value-based care arrangements.

91

91

PharmaTimes

JANUARY 30, 2024

Around one million adults in the UK visit their GP every year due to chest pain

91

91

PharmaVoice

JANUARY 30, 2024

Despite a recent safety warning from the FDA, companies such as BMS and J&J stress that the benefits of their cancer therapies still outweigh the risks.

FDA 59

FDA Safety 59

PharmaTech

JANUARY 30, 2024

Various impurities can infiltrate the container closure system in pharmaceutical manufacturing. Understanding nitrosamines, elemental impurities, extractables, and leachables can help ensure the safety of the final product.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Safety Pharma Manufacturing 52

Advertisement

Distribution

Evolve Your Success

JANUARY 30, 2024

Are you on the cusp of transitioning to a career in medical device sales but uncertain about the steps to take? This episode could inspire you to finally embark on that transformative journey. Samuel Adeyinka sits down with Aaron Kopfinger , who shares his remarkable journey from pharma to a thriving career in medical device sales. A graduate of the Medical Sales Career Builder Program, Aaron unveils the challenges he faced, the pivotal moments that led him to pursue a change, and the impactful

Medical sales 52

Medical sales Sales Medical Pharma 52

PharmaTech

JANUARY 30, 2024

In this episode of the Drug Solutions Podcast, industry experts give an overview of the biosimilars market and discuss factors affecting not only their manufacture, but their upstake in the market as well.

Manufacturing 52

Manufacturing Marketing 52

Pharmaceutical Commerce

JANUARY 30, 2024

New England Journal of Medicine study provides a breakdown of how hospitals—especially those that qualify for discounts under the federal 340B Drug Pricing Program—are able to make a profit off insurer pharmaceutical expenditures.

Insurance 52

Insurance Medicine Pharmaceutical 52

PharmaTech

JANUARY 30, 2024

In this exclusive Drug Digest video interview, Felicity Thomas, Europe/senior editor, Pharmaceutical Technology Group, interviews an esteemed panel of experts from IPEC Americas about excipient grades.

Pharmaceutical 52

Pharmaceutical 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales